Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series. 2012

Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
Department of Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, 16711 TransCanada Hwy, Kirkland, Quebec, Canada H9H 3L1. nicolas.lachance21@gmail.com

Elevated levels of stearoyl-CoA desaturase (SCD) activity have been implicated in metabolic disorders such as obesity and type II diabetes. To circumvent skin and eye adverse events observed in rodents with systemically-distributed inhibitors, our research efforts have been focused on the search for new liver-targeting compounds. This work has led to the discovery of novel, potent and liver-selective acyclic linker SCD inhibitors. These compounds possess suitable cellular activity and pharmacokinetic properties to inhibit liver SCD activity in a mouse pharmacodynamic model.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
August 2009, Bioorganic & medicinal chemistry letters,
Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
June 2009, Bioorganic & medicinal chemistry letters,
Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
April 2009, Bioorganic & medicinal chemistry letters,
Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
June 2007, Journal of medicinal chemistry,
Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
February 2013, Bioorganic & medicinal chemistry letters,
Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
January 1995, Progress in lipid research,
Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
November 2011, Bioorganic & medicinal chemistry letters,
Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
February 2015, Bioorganic & medicinal chemistry,
Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
October 2010, Biochemical genetics,
Nicolas Lachance, and Sébastien Guiral, and Zheng Huang, and Jean-Philippe Leclerc, and Chun Sing Li, and Renata M Oballa, and Yeeman K Ramtohul, and Hao Wang, and Jin Wu, and Lei Zhang
April 2016, Nature chemical biology,
Copied contents to your clipboard!